Founded 2008, London-based growth equity firm managing €150m+ (Fund II). Invested 33+ companies incl. Evotix (exited 3.2x, £20m ARR), Azimo (fintech), Clue (investigations), Oxford Medical Simulation (VR healthcare). Team: 17 incl. 10 partners (Steven Dunne, Jens Düing, Mike Reid). 15+ exits, €1bn+ exit value past 5yrs. Value-add via Operating Partners.
Investment Focus
Investment Thesis
Purpose-driven European software scale-ups w/ €3m+ ARR, low churn. Series A/B focus (€5-20m cheques). Enterprise software, fintech, proptech, edtech, digital infrastructure, smart data. Operational value via Scale-Up Methodology: 100+ toolkits/podcasts. Backs founders w/ measurable social impact. Avoids consumer-only, no product-market fit, high churn models.
Interested in connecting?
Visit their website or reach out directly.